Taken together, the results from the Tgfbr1/Pten 2cKO mice validate our previous report on nude mice with transplanted tumors, which suggests that IL-13-PE may be an effective therapeutic agent for the treatment of HNSCC. Here, TGFBR1 is linked to head and neck squamous cell carcinoma.